Insider · CIK 0001768564
New Enterprise Associates 17, L.P.
Files at NEUE (NeueHealth, Inc.), KRRO (Korro Bio, Inc.), SGP (SpyGlass Pharma, Inc.). First filing Oct 6, 2025, latest Mar 12, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KRRO: Korro Bio, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | Korro Bio, Inc. | $2.3M 207,100 shares | +19% | +117% from low-78% from high | |
| 50Moderate | SpyGlass Pharma, Inc. | $15M 937,500 shares | +18% | - | |
| 15Weak | NeueHealth, Inc. | $1,890 280 shares | -0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | KRRO Korro Bio, Inc. | POpen-market purchase Common Stock | +207,100 | $11.11 | $2.3M | 1,297,893 | Mar 12, 2026 |
| Mar 10, 2026 | KRRO Korro Bio, Inc. | POpen-market purchase Pre-Funded Warrantsderivative | +242,945 | $11.11 | $2.7M | 242,945 | Mar 12, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Common Stock | +1,619,240 | - | - | 1,619,240 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Common Stock | +1,370,168 | - | - | 2,989,408 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Common Stock | +1,370,168 | - | - | 4,359,576 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Common Stock | +737,962 | - | - | 5,097,538 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | POpen-market purchase Common Stock | +937,500 | $16.00 | $15M | 6,035,038 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Series B Preferred Stockderivative | -1,619,240 | - | - | 0 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Series C-1 Preferred Stockderivative | -1,370,168 | - | - | 0 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Series C-2 Preferred Stockderivative | -1,370,168 | - | - | 0 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Series D Preferred Stockderivative | -737,962 | - | - | 0 | Feb 11, 2026 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Common Stock | +189,195 | $0.01 | $1,892 | 488,982 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | SOpen-market sale Common Stock | -280 | $6.75 | $1,890 | 488,702 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Common Stock | +186,128 | $0.01 | $1,861 | 674,830 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | FTax withholding Common Stock | -276 | $6.75 | $1,863 | 674,554 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Common Stock | -674,554 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivative | -189,195 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | AGrant or award Warrant (Right to Buy)derivative | +186,128 | - | - | 186,128 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Warrant (Right to Buy)derivative | -186,128 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Series A Convertible Perpetual Preferred Stockderivative | -75,000 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Series B Convertible Perpetual Preferred Stockderivative | -37,700 | - | - | 0 | Oct 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.